Kathleen Goetz
Kathleen Goetz's purchase track record
How the stock did after each of Kathleen Goetz's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/9/2024 | THQ | $12K | +8.2% | +18.4% | +10.4% |
| 4/9/2024 | HQH | $9K | +11.2% | +19.0% | +10.4% |
| 4/9/2024 | HQL | $5K | +12.6% | +20.1% | +10.4% |
| 4/9/2024 | THW | $3K | +6.8% | +10.5% | +10.4% |
| 3/23/2022 | HQL | $2K | -11.8% | -8.6% | -14.9% |
| 3/23/2022 | THW | $2K | +0.6% | -1.9% | -14.9% |
| 3/23/2022 | HQH | $2K | -8.2% | -7.2% | -14.9% |
| 3/23/2022 | THQ | $2K | -11.4% | -10.5% | -14.9% |
| 1/26/2022 | THW | $10K | +10.1% | +10.6% | -7.5% |
| 1/26/2022 | HQH | $10K | -1.4% | -4.3% | -7.5% |
| 1/26/2022 | HQL | $10K | -6.1% | -8.2% | -7.5% |
| 1/26/2022 | THQ | $10K | +3.7% | -0.8% | -7.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
HQH Healthcare Fund Draws Attention for High Dividend Yield. Recent articles highlight HQH's dividend yield, which stands at 10.07% according to current data. One piece notes a cash yield above 9%, while another describes the fund as offering over 10% yield. These reports focus on the income potential of this healthcare-focused vehicle rather than recent operational changes.
Transaction History
| HQL | ▲ Buy | Open Market | 400 | $5K | 4/9/2024 | View on chart |
| HQH | ▲ Buy | Open Market | 525 | $9K | 4/9/2024 | View on chart |
| THW | ▲ Buy | Open Market | 200 | $3K | 4/9/2024 | View on chart |
| THQ | ▲ Buy | Open Market | 600 | $12K | 4/9/2024 | View on chart |
| HQL | ▲ Buy | Open Market | 92 | $2K | 3/23/2022 | View on chart |
| HQH | ▲ Buy | Open Market | 74 | $2K | 3/23/2022 | View on chart |
| THQ | ▲ Buy | Open Market | 69 | $2K | 3/23/2022 | View on chart |
| THW | ▲ Buy | Open Market | 103 | $2K | 3/23/2022 | View on chart |
| HQL | ▲ Buy | Open Market | 593 | $10K | 1/26/2022 | View on chart |
| HQH | ▲ Buy | Open Market | 481 | $10K | 1/26/2022 | View on chart |
| THW | ▲ Buy | Open Market | 714 | $10K | 1/26/2022 | View on chart |
| THQ | ▲ Buy | Open Market | 479 | $10K | 1/26/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
HQL Listed Among Top CEFs for September 2026 Yield
abrdn Life Sciences Investors (HQL) was included in a recent list of the ten best closed-end funds for September 2026, which highlights an average yield of 10%. This inclusion suggests the fund is being noted for its income potential within the broader CEF market. The stock is currently trading near its support level, reflecting a mixed technical picture alongside this fundamental recognition.
HQL Listed Among Top CEFs for September 2026 Yield. abrdn Life Sciences Investors (HQL) was included in a recent list of the ten best closed-end funds for September 2026, which highlights an average yield of 10%. This inclusion suggests the fund is being noted for its income potential within the broader CEF market. The stock is currently trading near its support level, reflecting a mixed technical picture alongside this fundamental recognition.